AMANDA HILL: Open Payments
NPI 1184269771 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,210 in 93 payments from 12 companies in 2025. Trend: 2023 $1,226 · 2024 $1,276 · 2025 $2,210
Food & beverage: $2,096Education: $114
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $851 |
| Vanda Pharmaceuticals Inc. | 17 | $311 |
| Teva Pharmaceuticals USA, Inc. | 6 | $281 |
| Otsuka America Pharmaceutical, Inc. | 6 | $222 |
| Neurocrine BioSciences, Inc. | 4 | $96 |
| Alkermes, Inc. | 4 | $90 |
| Lundbeck LLC | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
| Janssen Pharmaceuticals, Inc | 4 | $75 |
| Axsome Therapeutics, Inc. | 4 | $71 |
Products named: VRAYLAR, FANAPT, REXULTI, AUSTEDO XR, INGREZZA, ARISTADA, COBENFY, Auvelity.
Industry payments across MO — which companies pay providers there.
